Page last updated: 2024-08-22

limonene and Cancer of Liver

limonene has been researched along with Cancer of Liver in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Allison, M; Allsworth, M; Boyle, B; Calcagno, M; de Saedeleer, A; Debiram-Beecham, I; Ferrandino, G; Gandelman, O; Hoare, M; Kibble, G; Lydon, AM; Mayhew, CA; Orf, I; Smith, R; Snowdon, VK; Thind, AK; van der Schee, MP; Williams, M1
Abdulamir, AS; Abu Bakar, F; Hafidh, RR; Hussein, SZ; MalAllah, MQ1
Jia, L; Liu, Y; Mao, X; Wang, B; Xu, H; Zhao, Y1
Ishiguro, H; Kawata, S; Matsuzawa, Y; Nagase, T; Yamasaki, E1
Branch, SK; Broitman, SA; Cerda, S; Wilkinson, J1

Other Studies

5 other study(ies) available for limonene and Cancer of Liver

ArticleYear
Breath Biopsy Assessment of Liver Disease Using an Exogenous Volatile Organic Compound-Toward Improved Detection of Liver Impairment.
    Clinical and translational gastroenterology, 2020, Volume: 11, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Breath Tests; Carcinoma, Hepatocellular; Case-Control Studies; Cross-Sectional Studies; Female; Humans; Limonene; Liver; Liver Cirrhosis; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Volatile Organic Compounds

2020
A High-throughput Quantitative Expression Analysis of Cancer-related Genes in Human HepG2 Cells in Response to Limonene, a Potential Anticancer Agent.
    Current cancer drug targets, 2018, Volume: 18, Issue:8

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Drug Discovery; Flow Cytometry; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Hep G2 Cells; Humans; Limonene; Linear Models; Liver Neoplasms; Microscopy, Confocal; Oncogenes; Plant Extracts; Real-Time Polymerase Chain Reaction; Transcriptome; Treatment Outcome

2018
siRNA-targeted COL8A1 inhibits proliferation, reduces invasion and enhances sensitivity to D-limonence treatment in hepatocarcinoma cells.
    IUBMB life, 2009, Volume: 61, Issue:1

    Topics: Animals; Anticarcinogenic Agents; Blotting, Western; Carcinoma; Cell Line, Tumor; Cell Proliferation; Collagen Type VIII; Cyclohexenes; DNA Primers; Gene Expression Regulation, Neoplastic; Limonene; Liver Neoplasms; Mice; Neoplasm Invasiveness; RNA Interference; RNA, Small Interfering; Terpenes

2009
Modulation of the mevalonate pathway and cell growth by pravastatin and d-limonene in a human hepatoma cell line (Hep G2).
    British journal of cancer, 1994, Volume: 69, Issue:6

    Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Division; Cell Line; Cholesterol; Cyclohexenes; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Interactions; Humans; Kinetics; Limonene; Liver Neoplasms; Mevalonic Acid; Pravastatin; Protein Prenylation; Proto-Oncogene Proteins p21(ras); Terpenes; Tumor Cells, Cultured

1994
Effects of monoterpenes and mevinolin on murine colon tumor CT-26 in vitro and its hepatic "metastases" in vivo.
    Advances in experimental medicine and biology, 1996, Volume: 401

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Colonic Neoplasms; Cyclohexenes; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Limonene; Liver Neoplasms; Lovastatin; Mice; Mice, Inbred BALB C; Monoterpenes; Protein Prenylation; Terpenes; Tumor Cells, Cultured

1996